Type II cryoglobulinemic vasculitis in patients with Sjögren disease is associated with nearly a sevenfold increased risk for lymphoma and death in a study.
Among patients with primary Sjögren disease, type II cryoglobulinemic vasculitis is linked to an increased risk for lymphoma and mortality, a French study showed.Researchers conducted a retrospective multicenter cohort study of 54 patients with primary Sjögren disease and cutaneous vasculitis from three pathology departments in Paris and a national case call in France .
Patients were diagnosed with CV between 2011 and 2021; 29 had cryoglobulinemic vasculitis and 15 had hypergammaglobulinemic vasculitis; 24 of the 29 cryoglobulinemic cases were type II. Data were analyzed between March 2023 and March 2025. Patients were matched 1:2 to 108 controls with Sjögren disease but without CV from the French ASSESS cohort.=.02) than those with other types of small-vessel vasculitis. The risk for death or non-Hodgkin lymphoma was increased by nearly sevenfold risk in patients with type II cryoglobulinemic vasculitis (hazard ratio , 6.8;Among 24 patients with type II cryoglobulinemic vasculitis, 12 received rituximab-based first-line treatment; non-Hodgkin lymphoma developed in 8% of patients in the rituximab group and in 25% of those who received other treatments, whereas mortality rates were 33% and 25%, respectively.“In this cohort study, among patients with CV-complicated Sjögren disease, only type II cryoglobulinemic vasculitis was associated with severe visceral involvement, higher risk of non-Hodgkin lymphoma, and mortality,” the study authors wrote. These findings, they added, highlighted the need for “specific monitoring for these patients.”The retrospective design and potential missing data could affect the interpretation of results. Additionally, half of the patients were diagnosed with CV on the basis of clinical criteria.The ASSESS cohort was set up with a grant from the French Ministry of Health. One author reported receiving personal fees from Bristol Myers Squibb, GSK, Novartis, and Otsuka; another author reported receiving grants from AstraZeneca, Bristol Myers Squibb, and GSK. No other disclosures were reported. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our
Vasculitides Angiitis Lymphoma Malignant Lymphoma Non-Hodgkin' S Lymphoma Non-Hodgkin Lymphoma NHL Non-Hodgkin Lymphoma (NHL) Prognosis Antineoplastic Drug Anti-Cancer Agents Erlotinib Gefitinib Imatinib Rituximab Su11248 Sunitinib Trastuzumab Grant Monoclonal Antibody Cetuximab Rituximab Biologic Therapy Biologics Artificial Intelligence Deep Learning AI NPL
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Barbie Launches First Doll With Type 1 Diabetes: ‘Kids Can See Themselves’The doll carries a glucose monitor and an insulin pump that come in Barbie’s signature pink.
Read more »
Barbie's first doll with Type 1 diabetes comes complete with accurate glucose monitor, insulin pumpToday's Video Headlines: 070925
Read more »
Barbie debuts doll with Type 1 diabetes, insulin pumpThe new Barbie is part of the Fashionista series, which celebrates diversity.
Read more »
Barbie's 1st Doll With Type 1 Diabetes Includes Glucose Monitor, Insulin PumpJoyann Jeffrey is a trending news reporter based in New York City
Read more »
Barbie introduces 1st doll with Type 1 diabetes, and fans are getting emotional'The doll represents the incredible people living with T1D, and shows kids that a life with this condition is just as vibrant,' Mattel said.
Read more »
Mattel introduces first-ever Barbie doll with type 1 diabetesMattel and Breakthrough T1D teamed up to create a new Barbie meant to help and educate children: the first-ever Barbie doll with type 1 diabetes.
Read more »